CHM chimeric therapeutics limited

Paul Hopper comes with credentials. "He is the former Chairman...

  1. 56 Posts.
    lightbulb Created with Sketch. 9
    Paul Hopper comes with credentials.

    "He is the former Chairman of Viralytics Ltd (acquired by Merck for $500m in 2018), Founder and Director of Prescient Therapeutics Ltd, Founder of Imugene Ltd and Polynoma LLC, former Director of pSivida Corp, Somnomed Ltd and Fibrocell Science, Inc.". Also now the chairman of SUD.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $599 149.6K

Buyers (Bids)

No. Vol. Price($)
3 4665554 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 18587873 22
View Market Depth
Last trade - 10.00am 27/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.